Of note, anti-IgE treatment enhances antiviral immunity via a downregulation of the high-affinity IgE receptor (FcεRI) on plasmacytoid dendritic cells (pDCs) [7], resulting in a reduction of viral exacerbations in asthma [8, 9]. Here, IGHE is linked to asthma.